Advertisement
Most Americans report having excellent or good health and have a usual place to go for medical care

CDC: Most Americans Report Excellent, Good Health

0
Most health measures remained stable from 2017; percent of adults who have been tested for HIV increased
Bempedoic acid

Adding Bempedoic Acid to Statin Therapy Reduces LDL Cholesterol

0
Genetic variants mimicking effect of ATP citrate lyase inhibitors, statins lower LDL-C in same way
A short regimen is noninferior to a long regimen for patients with rifampin-resistant tuberculosis that is susceptible to fluoroquinolones and aminoglycosides

Short Regimen Noninferior for Rifampin-Resistant Tuberculosis

0
Short regimen of nine to 11 months noninferior to 20-month regimen following WHO guidelines
The U.S. Food and Drug Administration will temporarily be overseen by the head of the National Cancer Institute when FDA Commissioner Scott Gottlieb

Head of National Cancer Institute Named Acting FDA Commissioner

0
Current commissioner, Scott Gottlieb, will be stepping down in April
The U.S. Food and Drug Administration on Tuesday approved a new generic version of the high blood pressure/heart failure drug valsartan

FDA Approves New Generic Valsartan to Ease Shortage

0
Certain lots of valsartan recalled due to contamination with trace amounts of nitrosamine
An opioid supply for seven or fewer days might be sufficient for most patients seen in primary care settings for acute pain who appear to need opioid analgesics

Four-to-Seven-Day Opioid Rx Likely Sufficient for Acute Pain Treatment

0
No more than one in five patients who filled an opioid analgesic prescription obtained a refill
The initial prescription of tramadol compared with commonly prescribed nonsteroidal anti-inflammatory drugs may be associated with increased all-cause mortality among patients with osteoarthritis

Tramadol May Up Mortality Risk in Osteoarthritis Patients

0
Findings for those initially prescribed tramadol compared with commonly prescribed NSAIDs
The U.S. Food and Drug Administration has given its blessing to the first immunotherapy regimen for breast cancer.

FDA Approves First Immunotherapy Drug for Breast Cancer

0
Combo of Tecentriq and chemo given accelerated approval for triple-negative breast cancer
Monthly long-acting cabotegravir and rilpivirine are noninferior to daily regimens for patients with HIV-1

Long-Acting Regimen Noninferior to Daily ART for HIV-1

0
Monthly long-acting cabotegravir and rilpivirine noninferior in two randomized controlled trials
Kidney transplant recipients receiving Medicare who lose coverage before or after the current three-year policy time point have an increased risk for allograft loss

Timing of Medicare Loss Linked to Kidney Transplant Outcomes

0
Medication possession ratio lower for recipients with early, late Medicare loss versus no coverage loss